MY
Michael Yee Jefferies Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$65.3M
| $1.22 | $3 |
146%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
2
Kodiak Sciences
KOD
$556M
| $10.52 | $20 |
90%
upside
| Buy |
9 Dec ‘24
9 months ago |
|
3
Biogen
BIIB
$20.6B
| $140.67 | $180 |
28%
upside
| Hold |
9 Dec ‘24
9 months ago |
|
4
Vertex Pharmaceuticals
VRTX
$102B
| $396.12 | $550 |
39%
upside
| Buy |
9 Dec ‘24
9 months ago |
|
5
Amgen
AMGN
$153B
| $283.64 | $380 |
34%
upside
| Buy |
12 Nov ‘24
9 months ago |
|
6
Denali Therapeutics
DNLI
$2.26B
| $15.43 | $45 |
192%
upside
| Buy |
1 Nov ‘24
10 months ago |
|
7
Moderna
MRNA
$9.78B
| $25.14 | $55 |
119%
upside
| Hold |
15 Oct ‘24
10 months ago |
|
|
MBX
8
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $11.55 | $35 |
203%
upside
| Buy |
8 Oct ‘24
11 months ago |
|
|
ORKA
9
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
| $16.35 | $40 |
145%
upside
| Buy |
13 Sep ‘24
1 year ago |
|
10
Axon Enterprise
AXON
$57.2B
| $728.41 | $385 |
47%
downside
| Buy |
17 Jul ‘24
1 year ago |
|
11
Nuvation Bio
NUVB
$1.33B
| $3.90 | $10 |
156%
upside
| Buy |
27 Mar ‘24
1 year ago |
|
12
Immuneering
IMRX
$229M
| $5.51 | $3 |
46%
downside
| Hold |
15 Mar ‘24
1 year ago |
|
13
Beam Therapeutics
BEAM
$2.11B
| $20.88 | $30 |
44%
upside
| Hold |
8 Dec ‘23
1 year ago |
|
|
AMRN
14
Amarin Corp
AMRN
$317M
| $15.33 | $20 |
30%
upside
| Hold |
25 Oct ‘23
1 year ago |
|
15
Scholar Rock
SRRK
$3.02B
| $31.41 | $20 |
36%
downside
| Buy |
25 Oct ‘23
1 year ago |
|
16
Aligos Therapeutics
ALGS
$78.8M
| $11.34 | $75 |
561%
upside
| Buy |
6 Jan ‘23
2 years ago |
|
17
Invivyd
IVVD
$239M
| $1.14 | $10 |
777%
upside
| Hold |
22 Dec ‘21
3 years ago |
|
18
Ventyx Biosciences
VTYX
$180M
| $2.52 | $30 |
1,090%
upside
| Buy |
15 Nov ‘21
3 years ago |
|
19
Immunocore
IMCR
$1.87B
| $37.20 | $65 |
75%
upside
| Buy |
2 Mar ‘21
4 years ago |
|
20
FibroGen
FGEN
$48.9M
| $12.10 | $1,125 |
9,198%
upside
| Hold |
2 Mar ‘21
4 years ago |
|
21
Esperion Therapeutics
ESPR
$540M
| $2.68 | $30 |
1,019%
upside
| Hold |
12 Feb ‘21
4 years ago |
|
22
Prothena Corp
PRTA
$460M
| $8.55 | $30 |
251%
upside
| Buy |
12 Feb ‘21
4 years ago |
|
23
Assembly Biosciences
ASMB
$183M
| $23.82 | $120 |
404%
upside
| Hold |
6 Nov ‘20
4 years ago |
|
24
Schrodinger
SDGR
$1.41B
| $19.13 | $75 |
292%
upside
| Buy |
12 Oct ‘20
4 years ago |
|
|
25
Kodiak Sciences
KOD
$556M
| $10.52 | $100 |
851%
upside
| Buy |
3 Jan ‘20
5 years ago |
|